More than 400 people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic ...
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
On the basis of the data suggesting that adolescents and young adult patients with acute lymphoblastic leukemia (ALL ... fewer than five white blood cells on CSF cell count, with blasts on ...